NVCR Q3 2022 Earnings — NovoCure Limited Revenue & Financial Results | Market Cap Arena

NVCRNovoCure Limited

$1B

Q3 2022 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$131M-2.0% YoY

Gross Profit

$101M77.3% margin

Operating Income

-$25M-18.8% margin

Net Income

-$27M-20.3% margin

EPS (Diluted)

$-0.25

QoQ Revenue Growth

-7.0%

Cash Flow

Operating Cash Flow

$22M

Free Cash Flow

$17M

Stock-Based Comp.

$26M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$729M

Stockholders' Equity

$445M

Cash & Equivalents

$244M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$131M	$134M	-2.0%
Gross Profit	$101M	$103M	-2.1%
Operating Income	-$25M	-$9M	-187.8%
Net Income	-$27M	-$13M	-102.5%

Geographic Segments

UNITED STATES

$103M78%

JAPAN

$8M6%

EMEA, Exculding Germany

$8M6%

GERMANY

$7M5%

CHINA

$6M5%